Joseph Chandler, Ph.D., President of MBSAsia, Ltd. announced on March 18, 2008 that Maine Biotechnology Services, Inc, (MBS) is decided to open its first satellite facility at the Thailand Science Park. MBS has been providing its products and services to the world-wide biopharmaceutical and diagnostic markets. More recently, MBS has increased its presence in the Asian market. To meet the needs of its Asian customer base, MBS is opening a facility in Asian to better serve this expanding market and chose Thailand Science Park as their base.
MBS, founded in 1990 and based in Portland, Maine, USA, is a contract developer and manufacturer of monoclonal and polyclonal antibodies. Services provided include hybridoma development, polyclonal antibody development, ascites and in vitro production and purification. MBS also offers a large selection of bulk & OEM monoclonal and polyclonal antibodies for diagnostic, pharmaceutical and research applications. For more information about MBS please go to www.mainebiotechnology.com.
This news is provided by Thailand Science Park
Posted on 20 March 2008.